These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16899348)

  • 21. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic otitis media.
    Vazquez A; Blake DM; Jyung RW
    Ear Nose Throat J; 2014 Feb; 93(2):E27. PubMed ID: 24526488
    [No Abstract]   [Full Text] [Related]  

  • 23. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE; Kang YS; Cho Y; Park MK
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Seromucous otitis].
    Tran Ba Huy P; Sauvaget E; Portier F
    Ann Otolaryngol Chir Cervicofac; 2007 Jul; 124(3):120-5. PubMed ID: 17434139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.
    Bischoff L; Derk CT
    Int J Dermatol; 2008 Jan; 47(1):29-35. PubMed ID: 18173597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bordetella pertussis causing otitis media: a case report.
    Decherd ME; Deskin RW; Rowen JL; Brindley MB
    Laryngoscope; 2003 Feb; 113(2):226-7. PubMed ID: 12567073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of allergy immunotherapy as a treatment for patients with chronic otitis media with effusion.
    Hurst DS
    Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1215-23. PubMed ID: 18541312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TH1/TH2 and regulatory cytokines in adults with otitis media with effusion.
    Kariya S; Okano M; Hattori H; Sugata Y; Matsumoto R; Fukushima K; Schachern PA; Cureoglu S; Paparella MM; Nishizaki K
    Otol Neurotol; 2006 Dec; 27(8):1089-93. PubMed ID: 16988618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal phenylephrine-surfactant treatment is not beneficial in otitis media with effusion.
    Johnson D; Chandrasekhar SS; Mautone AJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):1085-9. PubMed ID: 18524392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ramatroban (Baynas): a review of its pharmacological and clinical profile].
    Motobayashi Y; Imagawa W; Saida K
    Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):397-402. PubMed ID: 11778458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
    Chiang KC; Rizk JG; Nelson DJ; Krishnamurti L; Subbian S; Imig JD; Khan I; Reddy ST; Gupta A
    Expert Opin Ther Targets; 2022 Jan; 26(1):13-28. PubMed ID: 35068281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticosteroids in allergic inflammation: clinical benefits in otitis media with effusion.
    Dhooge I; Verbruggen K; Vandenbulcke L
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):327-33. PubMed ID: 16822387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis.
    Kim DH; Hoon Park K; Jin Kang Y
    J Int Adv Otol; 2024 Jul; 20(4):331-338. PubMed ID: 39161176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that 13-14 di-hydro, 15-keto prostaglandin D(2)-induced airway eosinophilia in guinea-pigs is independent of interleukin-5.
    Whelan CJ
    Inflamm Res; 2009 Feb; 58(2):103-8. PubMed ID: 19184361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical diagnosis and treatment of eosinophilic otitis media].
    Zhang YZ; Wei XY; Chen ZC; Sun M; Cheng Y; Gao Y; Chen FY; Hu J; Xu M; Zhang Q; Fan MY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):160-163. PubMed ID: 30808144
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-Fluorouracil ointment for the treatment of otitis media with effusion.
    Kanemaru S; Nakamura T; Yamashita M; Magrfov A; Omori K; Ito J
    Laryngoscope; 2007 Feb; 117(2):215-9. PubMed ID: 17277614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The links between allergy and otitis media with effusion.
    Tewfik TL; Mazer B
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):187-90. PubMed ID: 16728898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ototopical antihistamine on otitis media in an allergic rat.
    Cutler JL; Labadie RF
    Laryngoscope; 2008 Feb; 118(2):283-7. PubMed ID: 18025947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ototoxicity of ototopical drops--an update.
    Haynes DS; Rutka J; Hawke M; Roland PS
    Otolaryngol Clin North Am; 2007 Jun; 40(3):669-83, xi. PubMed ID: 17544701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.